Skip to main content
WeightCited

5-HTP Emotional Eating

C エビデンス 小規模研究からのエビデンスは限られていますが、いくつかの肯定的なシグナルがあります。

As a serotonin precursor, 5-HTP may reduce emotional and stress-driven eating through modulation of hypothalamic satiety centers and reward pathways. Pilot studies show reduced carbohydrate cravings. Must avoid combination with SSRIs due to serotonin syndrome risk.

<\/script>\n
`; }, get iframeSnippet() { const domain = 'weightcited.com'; const params = 'ingredient\u003D5\u002Dhtp\u0026condition\u003Demotional\u002Deating'; return ``; }, get activeSnippet() { return this.method === 'script' ? this.scriptSnippet : this.iframeSnippet; }, copySnippet() { navigator.clipboard.writeText(this.activeSnippet).then(() => { this.copied = true; setTimeout(() => { this.copied = false; }, 2000); }); } }" @keydown.escape.window="open = false" @click.outside="open = false">

Embed This Widget

Style



      
      
    

Widget powered by . Free, no account required.

C

結論

As a serotonin precursor, 5-HTP may reduce emotional and stress-driven eating through modulation of hypothalamic satiety centers and reward pathways. Pilot studies show reduced carbohydrate cravings. Must avoid combination with SSRIs due to serotonin syndrome risk.

Key Study Findings

In Vitro
Enhanced production of 5-hydroxytryptophan through the regulation of L-tryptophan biosynthetic pathway.
Dose: recombinant E. coli strain for 5-HTP biosynthesis (engineered pathway) vs: Placebo 効果: 5-HTP production increased to 1.61 g/L (24% improvement); residual L-trp reduced from 1.66 to 0.2 g/ None

Key Statistics

3

研究数

80

参加者数

Positive

C

グレード

Referenced Papers

Alternative medicine review … 1998 216 件の引用

Dosage & Usage

mg = milligrams · mcg = micrograms (1,000× smaller) · IU = International Units

一般的な使用量

general:
50-100 mg 1-3x/day
starting:
50 mg/day and titrate up
appetitecontrol:
250-300 mg/day 30 min before meals

上限量: 500 mg/day; avoid combining with SSRIs, SNRIs, MAOIs, or triptans (serotonin syndrome risk)

研究で検討された用量

用量 期間 効果 N
recombinant E. coli strain for 5-HTP biosynthesis (engineered pathway) -- Positive --

推奨摂取タイミング: 30 minutes before meals on an empty stomach

Safety & Side Effects

報告されている副作用

  • Nausea
  • Drowsiness
  • GI discomfort
  • Serotonin syndrome risk with contraindicated medications

既知の相互作用

  • SSRIs (serotonin syndrome risk — NEVER combine)
  • SNRIs (serotonin syndrome risk — NEVER combine)
  • MAOIs (serotonin syndrome risk — NEVER combine)
  • Triptans (serotonin syndrome risk)
  • Carbidopa

耐容上限摂取量: 500 mg/day; avoid combining with SSRIs, SNRIs, MAOIs, or triptans (serotonin syndrome risk)

サプリメントの摂取を開始する前に、必ず医療専門家にご相談ください。

Frequently Asked Questions

Does 5-HTP help with Emotional Eating?
Based on 3 studies with 80 participants, there is limited but promising evidence that 5-HTP may support Emotional Eating management. Our evidence grade is C (Some Evidence).
How much 5-HTP should I take for Emotional Eating?
Studies have used various dosages. A commonly studied range is 50-100 mg 1-3x/day. Always consult your healthcare provider before starting any supplement regimen.
Are there side effects of 5-HTP?
Reported side effects may include Nausea, Drowsiness, GI discomfort, Serotonin syndrome risk with contraindicated medications. Most side effects are mild and dose-dependent. Consult your doctor if you experience any adverse reactions.
How strong is the evidence for 5-HTP and Emotional Eating?
We rate the evidence as Grade C (Some Evidence). This rating is based on 3 peer-reviewed studies with 80 total participants. The overall direction of effect is positive.

に関する他の成分: Emotional Eating

5-HTP 他の症状・状態について

References

  1. [1] Da Xu et al.. Appl Microbiol Biotechnol. 2020. Enhanced production of 5-hydroxytryptophan through the regulation of L-tryptophan biosynthetic pathway. doi:10.1007/s00253-020-10371-y PubMed
  2. [2] T C Birdsall. Altern Med Rev. 1998. 5-Hydroxytryptophan: a clinically-effective serotonin precursor. PubMed

FDAに関する免責事項: これらの記述は米国食品医薬品局(FDA)による評価を受けていません。本ウェブサイトの製品および情報は、疾病の診断、治療、治癒、または予防を目的としたものではありません。表示されているエビデンスグレードは、公開された査読済み研究の分析に基づいており、医療上の助言を構成するものではありません。サプリメントの摂取を開始する前に、必ず医療専門家にご相談ください。